Kyle W. Gano

2020

In 2020, Kyle W. Gano earned a total compensation of $7.2M as Chief Development and Strategy Officer at Neurocrine Biosciences, a 53% increase compared to previous year.

Compensation breakdown

Bonus$207,273
Option Awards$3,749,799
Salary$487,700
Stock Awards$2,750,210
Other$16,751
Total$7,211,733

Gano received $3.7M in option awards, accounting for 52% of the total pay in 2020.

Gano also received $207.3K in bonus, $487.7K in salary, $2.8M in stock awards and $16.8K in other compensation.

Rankings

In 2020, Kyle W. Gano's compensation ranked 1,342nd out of 13,090 executives tracked by ExecPay. In other words, Gano earned more than 89.7% of executives.

ClassificationRankingPercentile
All
1,342
out of 13,090
90th
Division
Manufacturing
485
out of 5,621
91st
Major group
Chemicals And Allied Products
170
out of 2,254
93rd
Industry group
Drugs
146
out of 1,954
93rd
Industry
Biological Products, Except Diagnostic Substances
41
out of 411
90th

Pay ratio

Kyle W. Gano's Pay$7,211,733
Median Employee's Pay$241,848
Pay Ratio

30

to 1

In 2020, the annual total compensation of Kyle W. Gano was $7,211,733.

The annual total compensation of the median employee at Neurocrine Biosciences was $241,848.

The ratio of Kyle W. Gano's pay to the pay of median employee was therefore 30 to one.

Source: SEC filing on April 9, 2021.

Gano's colleagues

We found four more compensation records of executives who worked with Kyle W. Gano at Neurocrine Biosciences in 2020.

2020

Kevin Gorman

Neurocrine Biosciences

Chief Executive Officer

2020

Eric Benevich

Neurocrine Biosciences

Chief Commercial Officer

2020

Matthew Abernethy

Neurocrine Biosciences

Chief Financial Officer

2020

Eiry Roberts

Neurocrine Biosciences

Chief Medical Officer

News

In-depth

You may also like